Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 402

1.

Quadrivalent influenza vaccines in low and middle income countries: Cost-effectiveness, affordability and availability.

Hendriks J, Hutubessy RCW, Grohmann G, Torelli G, Friede M, Kieny MP.

Vaccine. 2018 Jun 27;36(28):3993-3997. doi: 10.1016/j.vaccine.2018.05.099. Epub 2018 Jun 6.

2.

Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a phase I randomized clinical trial in healthy Serbian adults.

Stevanovic G, Lavadinovic L, Filipovic Vignjevic S, Holt R, Ilic K, Berlanda Scorza F, Sparrow E, Stoiljkovic V, Torelli G, Madenwald T, Socquet M, Barac A, Ilieva-Borisova Y, Pelemis M, Flores J.

Hum Vaccin Immunother. 2018 Mar 4;14(3):579-586. doi: 10.1080/21645515.2017.1415683. Epub 2018 Feb 23.

3.

Deregulated expression and activity of Farnesyl Diphosphate Synthase (FDPS) in Glioblastoma.

Abate M, Laezza C, Pisanti S, Torelli G, Seneca V, Catapano G, Montella F, Ranieri R, Notarnicola M, Gazzerro P, Bifulco M, Ciaglia E.

Sci Rep. 2017 Oct 26;7(1):14123. doi: 10.1038/s41598-017-14495-6.

4.

Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor.

Ciaglia E, Abate M, Laezza C, Pisanti S, Vitale M, Seneca V, Torelli G, Franceschelli S, Catapano G, Gazzerro P, Bifulco M.

Int J Cancer. 2017 Feb 15;140(4):959-972. doi: 10.1002/ijc.30505. Epub 2016 Nov 16.

5.

Stakeholders' perceptions of 10years of the Global Action Plan for Influenza Vaccines (GAP) - Results from a survey.

Nannei C, Goldin S, Torelli G, Fatima H, Kumar K, Bubb-Humfryes O, Stenson B, Sparrow E.

Vaccine. 2016 Oct 26;34(45):5393-5399. doi: 10.1016/j.vaccine.2016.08.040. Epub 2016 Sep 16.

6.

The 2015 global production capacity of seasonal and pandemic influenza vaccine.

McLean KA, Goldin S, Nannei C, Sparrow E, Torelli G.

Vaccine. 2016 Oct 26;34(45):5410-5413. doi: 10.1016/j.vaccine.2016.08.019. Epub 2016 Aug 13.

7.

The antileukemic potential of natural killer cells.

Torelli GF, Peragine N, Mariglia P, Foà R.

Immunotherapy. 2016;8(4):425-34. doi: 10.2217/imt-2015-0009. Review.

PMID:
26973124
8.

Posaconazole oral suspension primary prophylaxis in acute leukemia and allogeneic stem cell transplant patients: can it be used without measurement of plasma concentration?

Girmenia C, Annino L, Mariotti B, Fanci R, Minotti C, Spadea A, Carotti A, Piedimonte M, Chierichini A, Cerchiara E, Caselli D, Cupelli L, Arcioni F, Bertaina A, Ribersani M, Proia A, Mengarelli A, Perriello V, Torelli GF, Di Gioia M, Del Principe MI, Cassetta MI, Fallani S, Novelli A.

Med Mycol. 2016 Jul 1;54(5):445-58. doi: 10.1093/mmy/myw001. Epub 2016 Feb 11.

PMID:
26868905
9.

Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial.

Rambaldi A, Grassi A, Masciulli A, Boschini C, Micò MC, Busca A, Bruno B, Cavattoni I, Santarone S, Raimondi R, Montanari M, Milone G, Chiusolo P, Pastore D, Guidi S, Patriarca F, Risitano AM, Saporiti G, Pini M, Terruzzi E, Arcese W, Marotta G, Carella AM, Nagler A, Russo D, Corradini P, Alessandrino EP, Torelli GF, Scimè R, Mordini N, Oldani E, Marfisi RM, Bacigalupo A, Bosi A.

Lancet Oncol. 2015 Nov;16(15):1525-1536. doi: 10.1016/S1470-2045(15)00200-4. Epub 2015 Sep 28.

10.

Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells.

Ciaglia E, Torelli G, Pisanti S, Picardi P, D'Alessandro A, Laezza C, Malfitano AM, Fiore D, Pagano Zottola AC, Proto MC, Catapano G, Gazzerro P, Bifulco M.

Oncotarget. 2015 Jun 20;6(17):15464-81.

11.

A good manufacturing practice method to ex vivo expand natural killer cells for clinical use.

Torelli GF, Rozera C, Santodonato L, Peragine N, D'agostino G, Montefiore E, Napolitano MR, Monque DM, Carlei D, Mariglia P, Pauselli S, Gozzer M, Bafti MS, Girelli G, Guarini A, Belardelli F, Foà R.

Blood Transfus. 2015 Jul;13(3):464-71. doi: 10.2450/2015.0231-14. Epub 2015 Jan 30.

12.

Proven Epstein-Barr encephalitis with negative EBV-DNA load in cerebrospinal fluid after allogeneic hematopoietic stem cell transplantation in a child with acute lymphoblastic leukemia.

Barberi W, Perrone S, Iori AP, Torelli GF, Testi AM, Moleti ML, Ceglie T, Papoff P, Caresta E, Antonelli M, Gianno F, Melone A, Badiali M, Giangaspero F, Foà R, Gentile G.

Pediatr Transplant. 2015 Feb;19(1):E19-24. doi: 10.1111/petr.12386. Epub 2014 Nov 12.

PMID:
25388950
13.

Immunophenotypic and functional characterization of ex vivo expanded natural killer cells for clinical use in acute lymphoblastic leukemia patients.

Peragine N, Torelli GF, Mariglia P, Pauselli S, Vitale A, Guarini A, Foà R.

Cancer Immunol Immunother. 2015 Feb;64(2):201-11. doi: 10.1007/s00262-014-1614-z. Epub 2014 Oct 24.

PMID:
25341808
14.

A case of late isolated ovarian relapse of acute lymphoblastic leukemia after an allogeneic stem cell transplant.

Nunes V, Della Starza I, Canichella M, Cavalli M, De Propris MS, Messina M, Capria S, Torelli GF, Vitale A, Guarini A, Chiaretti S, Foà R.

Leuk Lymphoma. 2015 May;56(5):1517-20. doi: 10.3109/10428194.2014.956317. Epub 2014 Nov 5. No abstract available.

PMID:
25204371
15.

Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia.

Folgiero V, Goffredo BM, Filippini P, Masetti R, Bonanno G, Caruso R, Bertaina V, Mastronuzzi A, Gaspari S, Zecca M, Torelli GF, Testi AM, Pession A, Locatelli F, Rutella S.

Oncotarget. 2014 Apr 30;5(8):2052-64.

16.

Strongyloides stercoralis infection in allogeneic stem cell transplant: a case report and review of the literature.

Iori AP, Ferretti A, Gentile G, Gabrielli S, Perrone S, Barberi W, Torelli GF, Natalino F, Scalzulli E, Totino V, Foà R, Cancrini G, Girmenia C.

Transpl Infect Dis. 2014 Aug;16(4):625-30. doi: 10.1111/tid.12239. Epub 2014 Jun 3. Review.

PMID:
24890466
17.

Selective splenic artery embolization for the treatment of thrombocytopenia and hypersplenism in paroxysmal nocturnal hemoglobinuria.

Araten DJ, Iori AP, Brown K, Torelli GF, Barberi W, Natalino F, De Propris MS, Girmenia C, Salvatori FM, Zelig O, Foà R, Luzzatto L.

J Hematol Oncol. 2014 Mar 27;7:27. doi: 10.1186/1756-8722-7-27.

18.

Cytomegalovirus in bone marrow cells correlates with cytomegalovirus in peripheral blood leukocytes.

Capobianchi A, Iori AP, Micozzi A, Torelli GF, Testi AM, Girmenia C, Santilli S, Barberi W, Antonelli G, Foà R, Gentile G.

J Clin Microbiol. 2014 Jun;52(6):2183-5. doi: 10.1128/JCM.00702-14. Epub 2014 Mar 26.

19.

Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells.

Torelli GF, Peragine N, Raponi S, Pagliara D, De Propris MS, Vitale A, Bertaina A, Barberi W, Moretta L, Basso G, Santoni A, Guarini A, Locatelli F, Foà R.

Haematologica. 2014 Jul;99(7):1248-54. doi: 10.3324/haematol.2013.101931. Epub 2014 Mar 21.

20.

High grade glioblastoma is associated with aberrant expression of ZFP57, a protein involved in gene imprinting, and of CPT1A and CPT1C that regulate fatty acid metabolism.

Cirillo A, Di Salle A, Petillo O, Melone MA, Grimaldi G, Bellotti A, Torelli G, De' Santi MS, Cantatore G, Marinelli A, Galderisi U, Peluso G.

Cancer Biol Ther. 2014 Jun 1;15(6):735-41. doi: 10.4161/cbt.28408. Epub 2014 Mar 11.

21.

Apparent mtDNA sequence heterogeneity in single human blood CD34+ cells is markedly affected by storage and transport.

Yao YG, Kajigaya S, Samsel L, McCoy JP Jr, Torelli G, Young NS.

Mutat Res. 2013 Nov-Dec;751-752:36-41. doi: 10.1016/j.mrfmmm.2013.09.001. Epub 2013 Sep 14.

22.

Cyclophosphamide induces a type I interferon-associated sterile inflammatory response signature in cancer patients' blood cells: implications for cancer chemoimmunotherapy.

Moschella F, Torelli GF, Valentini M, Urbani F, Buccione C, Petrucci MT, Natalino F, Belardelli F, Foà R, Proietti E.

Clin Cancer Res. 2013 Aug 1;19(15):4249-61. doi: 10.1158/1078-0432.CCR-12-3666. Epub 2013 Jun 12.

23.

Accumulation of mtDNA variations in human single CD34+ cells from maternally related individuals: effects of aging and family genetic background.

Yao YG, Kajigaya S, Feng X, Samsel L, McCoy JP Jr, Torelli G, Young NS.

Stem Cell Res. 2013 May;10(3):361-70. doi: 10.1016/j.scr.2013.01.006. Epub 2013 Jan 29.

24.

The limit for chronic myeloid leukemia relapse after allogeneic hematopoietic stem cell transplant moves ever forward: when can you safely talk about healing?

Iori AP, Breccia M, Girmenia C, Perrone S, Valle V, Natalino F, Barberi W, Scalzulli E, Torelli GF, Puzzolo MC, Foà R.

Leuk Lymphoma. 2013 Mar;54(3):669-70. doi: 10.3109/10428194.2012.715348. Epub 2012 Oct 4. No abstract available.

PMID:
23036078
25.

Concentration of organic micropollutants in the atmosphere of Trieste, Italy.

Mosca S, Torelli GN, Tramontana G, Guerriero E, Rotatori M, Bianchini M.

Environ Sci Pollut Res Int. 2012 Jul;19(6):1927-35. doi: 10.1007/s11356-011-0696-9. Epub 2012 Jul 3.

PMID:
22767290
26.

First case of ovarian Sertoli-Leydig cell tumor after an allogeneic hematopoietic stem cell transplantation for Hodgkin's disease.

Perrone S, Pecorella I, Barberi W, Valle V, Torelli GF, Natalino F, Mercanti C, Foà R, Iori AP.

Leuk Res. 2012 Aug;36(8):e185-6. doi: 10.1016/j.leukres.2012.04.012. Epub 2012 May 23. No abstract available.

PMID:
22633001
27.

Program and read scaling trade-offs in phase change memories.

Braga S, Cabrini A, Torelli G.

J Nanosci Nanotechnol. 2011 Dec;11(12):10470-5.

PMID:
22408928
28.

Growth factor-associated graft-versus-host disease and mortality 10 years after allogeneic bone marrow transplantation.

Ringdén O, Labopin M, Gorin NC, Volin L, Torelli GF, Attal M, Jouet JP, Milpied N, Socié G, Cordonnier C, Michallet M, Atienza AI, Hermine O, Mohty M; Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation.

Br J Haematol. 2012 Apr;157(2):220-9. doi: 10.1111/j.1365-2141.2012.09034.x. Epub 2012 Feb 2.

PMID:
22299728
29.

Concurrent search for unrelated cord and volunteer donor in high-risk acute lymphoblastic leukemia.

Iori AP, Valle V, Piciocchi A, Meloni G, Torelli GF, Vitale A, Testi AM, Barberi W, Ricci R, Milano F, Lucarelli B, Screnci M, Perrone MP, Laurenti L, Natalino F, Perrone S, Sacchi N, Arcese W, Foà R.

Ann Hematol. 2012 Jun;91(6):941-8. doi: 10.1007/s00277-011-1392-z. Epub 2012 Jan 3.

PMID:
22209945
30.

Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells.

Maffei R, Fiorcari S, Bulgarelli J, Martinelli S, Castelli I, Deaglio S, Debbia G, Fontana M, Coluccio V, Bonacorsi G, Zucchini P, Narni F, Torelli G, Luppi M, Marasca R.

Haematologica. 2012 Jun;97(6):952-60. doi: 10.3324/haematol.2011.054924. Epub 2011 Dec 29.

31.

Longitudinal analysis of human herpesvirus-8 DNA and antibodies in an Italian allogeneic stem cell transplant recipient.

Capobianchi A, Iori AP, Mauro FR, Torelli GF, Micozzi A, Girmenia C, Foà R, Gentile G.

J Clin Virol. 2011 Nov;52(3):247-50. doi: 10.1016/j.jcv.2011.07.003. Epub 2011 Aug 11.

PMID:
21839673
32.

Functional analysis and gene expression profile of umbilical cord blood regulatory T cells.

Torelli GF, Maggio R, Peragine N, Chiaretti S, De Propris MS, Lucarelli B, Screnci M, Mascolo MG, Milano F, Iori AP, Girelli G, Guarini A, Foà R.

Ann Hematol. 2012 Feb;91(2):155-61. doi: 10.1007/s00277-011-1288-y. Epub 2011 Jul 6.

PMID:
21732086
33.

WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer.

Friede M, Palkonyay L, Alfonso C, Pervikov Y, Torelli G, Wood D, Kieny MP.

Vaccine. 2011 Jul 1;29 Suppl 1:A2-7. doi: 10.1016/j.vaccine.2011.02.079. Review.

34.

A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course.

Forghieri F, Morselli M, Potenza L, Maccaferri M, Pedrazzi L, Coluccio V, Barozzi P, Vallerini D, Riva G, Zanetti E, Quarelli C, Bonacorsi G, Artusi T, Zaldini P, Zucchini P, Marasca R, Narni F, Falini B, Torelli G, Luppi M.

Leuk Lymphoma. 2011 Oct;52(10):2012-9. doi: 10.3109/10428194.2011.584990. Epub 2011 Jun 3. No abstract available.

PMID:
21635206
35.

Evaluation of a simultaneous sampling method of PAHs, PCDD/Fs and dl-PCBs in ambient air.

Mosca S, Torelli GN, Guerriero E, Tramontana G, Pomponio S, Rossetti G, Rotatori M.

J Environ Monit. 2010 May;12(5):1092-9.

PMID:
21491678
36.

The immune reconstitution after an allogeneic stem cell transplant correlates with the risk of graft-versus-host disease and cytomegalovirus infection.

Torelli GF, Lucarelli B, Iori AP, De Propris MS, Capobianchi A, Barberi W, Valle V, Iannella E, Natalino F, Mercanti C, Perrone S, Gentile G, Guarini A, Foà R.

Leuk Res. 2011 Aug;35(8):1124-6. doi: 10.1016/j.leukres.2011.03.009. Epub 2011 Apr 2.

PMID:
21459444
37.

Early onset of posterior reversible encephalopathy syndrome (PRES) during Cyclosporine-A infusion.

Torelli GF, Natalino F, Barberi W, Iori AP, Andreoli C, Valle V, Mercanti C, Perrone S, Gualdi G, Foà R.

Leuk Res. 2011 Oct;35(10):1423-4. doi: 10.1016/j.leukres.2011.02.022. Epub 2011 Mar 11. No abstract available.

PMID:
21397327
38.

Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma.

Forghieri F, Morselli M, Potenza L, Maccaferri M, Pedrazzi L, Paolini A, Bonacorsi G, Artusi T, Giacobbi F, Corradini G, Barozzi P, Zucchini P, Marasca R, Narni F, Crescenzi B, Mecucci C, Falini B, Torelli G, Luppi M.

Eur J Haematol. 2011 Apr;86(4):352-5. doi: 10.1111/j.1600-0609.2011.01576.x. No abstract available.

PMID:
21226763
39.

Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma.

Zanetti E, Barozzi P, Brown EE, Bosco R, Vallerini D, Riva G, Quadrelli C, Potenza L, Forghieri F, Montagnani G, D'Amico R, Del Giovane C, Duraes C, Whitby D, Machado JC, Schulz TF, Torelli G, Luppi M.

Transplantation. 2010 Aug 15;90(3):337-8. doi: 10.1097/TP.0b013e3181e4e4d9. No abstract available.

PMID:
20683431
40.

Translational challenges of human herpesvirus 6 chromosomal integration.

Potenza L, Barozzi P, Torelli G, Luppi M.

Future Microbiol. 2010 Jul;5(7):993-5. doi: 10.2217/fmb.10.74. No abstract available.

41.

Clinical responses in allografted acute leukaemia patients with resistant disease using a combined chemo-immunotherapeutic treatment strategy.

Torelli GF, Natalino F, Barberi W, Maggio R, Peragine N, De Propris MS, Piciocchi A, Valle V, Iannella E, Iori AP, Guarini A, Foà R.

Br J Haematol. 2010 Oct;151(1):86-9. doi: 10.1111/j.1365-2141.2010.08291.x. Epub 2010 Jul 7. No abstract available.

PMID:
20618336
42.

Pregnancy in PNH: another eculizumab baby.

Marasca R, Coluccio V, Santachiara R, Leonardi G, Torelli G, Notaro R, Luzzatto L.

Br J Haematol. 2010 Sep;150(6):707-8. doi: 10.1111/j.1365-2141.2010.08258.x. No abstract available.

PMID:
20553271
43.

Cytogenetic abnormalities and clinical features in a patient cohort affected by three or more synchronous or metachronous primitive malignancies.

Ponti G, Luppi G, Giacobbi F, Corradini G, Temperani P, Losi L, Ferrara L, Pagano M, Seidenari S, Tagliafico E, Torelli G, Conte P.

Cancer Genet Cytogenet. 2010 Jul 1;200(1):1-7. doi: 10.1016/j.cancergencyto.2009.10.006.

PMID:
20513527
44.

Posttraumatic massive bleeding: a challenging multidisciplinary task.

Marietta M, Pedrazzi P, Girardis M, Busani S, Torelli G.

Intern Emerg Med. 2010 Dec;5(6):521-31. doi: 10.1007/s11739-010-0396-3. Epub 2010 May 20. Review.

PMID:
20490951
45.

Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia.

Maffei R, Martinelli S, Santachiara R, Rossi D, Guarnotta C, Sozzi E, Zucchetto A, Rigolin GM, Fiorcari S, Castelli I, Fontana M, Coluccio V, Leonardi G, Zucchini P, Tripodo C, Cuneo A, Gattei V, Del Poeta G, Forconi F, Gaidano G, Torelli G, Marasca R.

Blood. 2010 Jul 29;116(4):584-92. doi: 10.1182/blood-2009-11-252494. Epub 2010 Apr 9.

46.

Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukaemia groups (AML-19).

Amadori S, Suciu S, Selleslag D, Stasi R, Alimena G, Baila L, Rizzoli V, Borlenghi E, Gaidano G, Magro D, Torelli G, Muus P, Venditti A, Cacciola E, Lauria F, Vignetti M, de Witte T.

Br J Haematol. 2010 May;149(3):376-82. doi: 10.1111/j.1365-2141.2010.08095.x. Epub 2010 Mar 8.

47.
48.

Organising pneumonia mimicking invasive fungal disease in patients with leukaemia.

Forghieri F, Potenza L, Morselli M, Maccaferri M, Pedrazzi L, Barozzi P, Vallerini D, Riva G, Zanetti E, Quadrelli C, Rossi G, Rivasi F, Messino' M, Rumpianesi F, Grottola A, Venturelli C, Pecorari M, Codeluppi M, Torelli G, Luppi M.

Eur J Haematol. 2010 Jul;85(1):76-82. doi: 10.1111/j.1600-0609.2010.01427.x. Epub 2010 Feb 9.

PMID:
20148942
49.

HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role?

Forghieri F, Potenza L, Barozzi P, Vallerini D, Riva G, Zanetti E, Quadrelli C, Torelli G, Luppi M.

Leuk Lymphoma. 2010 Mar;51(3):565-7. doi: 10.3109/10428190903528286. No abstract available.

PMID:
20141437
50.

Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term imatinib mesylate treatment.

Riva G, Luppi M, Barozzi P, Quadrelli C, Basso S, Vallerini D, Zanetti E, Morselli M, Forghieri F, Maccaferri M, Volzone F, Del Giovane C, D'Amico R, Locatelli F, Torelli G, Comoli P, Potenza L.

Blood. 2010 Feb 25;115(8):1512-8. doi: 10.1182/blood-2009-06-230391. Epub 2009 Dec 10.

Supplemental Content

Loading ...
Support Center